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The purpose of this communication is to add two new cases of
idiosyncrasy to quinin to the long list of such instances encountered in
the literature, with an allusion to a skin reaction and attempts at
densensitization.
Case 1.-G. V. W., male, chief yeoman, aged 22 years, was admitted to
the U. S. Naval Hospital, Washington, D. C., as a case of influenza. His
illness pursued a typical course and in two weeks he had recovered completely.
During the latter days of his convalescence elixir of iron, quinin and strych-
nin were prescribed for him in 4 mil doses. Within fifteen minutes after
the first dose was administered, the eyes began to smart and itch. There
was some photophobia and lacrimation. Soon the face, neck, chest and hands
became a "lobster red" color, which rapidly became a generalized erythema.
This was attended by an intense pruritus. There was a certain degree of
headache, puffiness of the eyelids and muscae volitantes, but no vertigo nor
tinnitus aurium were noticed. Some dyspnea and epigastric burning were
encountered. The erythema and pruritus completely disappeared in two and
one-half hours.
On questioning the patient, it was learned that during childhood quinin was
frequently taken for coryzal attacks on which occasions no untoward symp-
toms occurred. Not until eight years ago was any reaction from this drug
noticed, when an attack, similar to the one just described, followed the inges-
tion of approximately 0.2 gm. of quinin. The second attack occurred one
year later, when a similar dose was taken. From this time on until two
years ago, the patient on several occasions took tablets containing, in addition
to other ingredients, 0.065 gm. of quinin. No ill effects were noticed from these
until October, 1917, when, after taking one tablet, a syndrome was caused,
characterized by erythema, pruritus, edema, headache, vertigo, tinnitus, muscae
volitantes, dyspnea, nausea and vomiting. Since 1917 the patient has not taken
quinin in any form until his admission to the Naval Hospital.
He says he can eat eggs, cucumbers, strawberries, tomatoes, buckwheat
and all types of sea food with impunity. He never had hay fever or horse
asthma. Typhoid or smallpox vaccine did not occasion any undue reaction.
His past, family and personal history reveal no noteworthy features
Physical examination is negative.
Case 2.-Captain S., U. S. Marine Corps, male, aged 28 years, married
was admitted to the U. S. Naval Hospital, Washington, D. C., complaining of
tenderness, weakness, loss of weight and stiffness in the legs and thighs
There was no cough and repeated physical examinations and thoracic roent-
genograms failed to reveal any tuberculous process. The patient had returned
* Published by permission of the Surgeon-General, U. S. Navy.
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on sick leave from eighteen months duty in San Domingo, where, since early
in March, 1918, he had experienced three definite attacks of benign tertian
malaria. The first two attacks were three months apart—in March and June,
1918. They were clinically typical and responded readily to 1 gm. of quinin
sulphate, three times a day. On both occasions absolutely no untoward effects
were caused by the quinin, nor had the patient ever had cinchonism prior to
this time, despite the fact that he had taken 1 gm. of quinin a day as a
prophylactic ten years previously while on an engineering expedition in South
America. In December, 1918, a third attack of malaria was experienced. As
in the previous two attacks, he had distinct chills, forty-eight hours apart,
and the plasmodium vivax was found in the blood smear. Quinin therapy was
instituted. The first dose, 1 gm. of quinin sulphate, produced no ill effects.
The second dose of the same size, given a few hours later, caused a blotchy,
diffuse rash, generalized pruritus, headache, tinnitus aurium, muscae volitantes,
photophobia, lacrimation, dyspnea, epigastric flushes of heat, nausea and diar¬
rhea. This attack persisted for several hours. Therefore the drug was dis¬
continued for two days and then given subcutaneously, once a day. Each
injection was attended by a syndrome similar to the first though milder. Hav¬
ing apparently recovered from malaria, the patient returned to this country.
Except for an attack of amebic dysentery in 1913, his health has always been
good. Has never had any hay fever, horse asthma nor any reactions to the
various fruits, vegetables, sea food or drugs other than quinin.
It would appear from an analysis of these cases that the hypersen-
sitiveness to quinin was acquired. In neither case could a similar
familial tendency be elicitetd. The clinical manifestations were
extremely suggestive of cinchonism, and it was found that neither
individual reacted with any of the other common drugs where idio¬
syncrasies are known to occur. Furthermore, it was found that the
tolerance of Case 1 was somewhat less than 0.03 gm. when given by
mouth, and that of Case 2 was about 0.25 gm. when given by mouth or
intravenously in a 5 per cent, solution. Both men failed to react
clinically with the other alkaloids of cinchona, whereas the various
salts of quinin produced a reaction in sufficient dosages.
After the method of Boerner,1 skin reactions were tried in both
cases. Two superficial abrasions were made with a sterile needle on
the flexor surface of the forearm, about 3 inches apart, after the parts
were cleansed with 95 per cent, ethyl alcohol and dried. To one was
applied quinin bisulphate (1: 10) while the other was left untouched,
functioning as a control. We were able to confirm Boerner's findings
in that the scarification to which the quinin antigen had been applied
showed a marked reaction in both men, while the control merely exhib¬
ited the results of the traumatism. The reactions began with an itching,
smarting or burning sensation from four to five minutes after applica¬
tion. This was quickly followed by an area of edema on either side
of the needle scratch. This edematous area was, as a rule, irregular
in outline and reached its height in from fifteen or twenty minutes to
one hour. It was surrounded by a bright red halo of erythema, which
1. Boerner, F., Jr.: J. A. M. A. 68:907 (March 24) 1917.
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varied from 3 to 5 cm. in diameter. An identical reaction could be
produced by the use of the chlorhydrosulphate or dihydrochlorid of
quinin in 1: 20 dilutions. Control tests, as shown in Figure 1, of salicy¬
lic acid (10 per cent.), caffein citrate (10 per cent.), potassium iodid(saturated solution), atropin sulphate (0.5 per cent.) and epinephrin(1:1,000) failed to provoke analogous reactions in either patient.
Later, additional controls were made, using cinchonin sulphate, and
cinchonidin sulphate as antigens. No reactions were encountered with
these alkaloids of cinchona, whereas the quinin yielded the usual
intense response.
Twelve individuals were selected who were known not to be hyper¬
sensitive to the drug. All were given as much as 2 gm. of quinin sul¬
phate a day without manifesting any discomfiture. The cutaneous tests
in all these men were negative. As Boerner indicated, there is reason
to believe that the reaction is specific to those who are hypersensitive
to quinin, and, also, it has been found that these two patients failed to
respond to other idiosyncrasy-producing drugs, even to certain other
alkaloids of cinchona.
An attempt was now made to desensitize the patients to quinin. The
procedure described by Heran and Saint Girons2 gave brilliant results
in Case 1, while the tolerance in Case 2 was increased from 0.25 to 0.7
gm. The method, briefly, consisted in giving by mouth a "desensitizing
dose" of 0.005 gm. with 0.5 gm. of sodium bicarbonate. In one hour
and thirty minutes, 0.1 gm. of quinin bisulphate and 0.5 gm. of sodium
bicarbonate were ingested in cachets. The "desensitizing dose"
remained constant each day, while, in the second dose, the amount of
quinin was increased 0.1 gm. each day. The quantity of sodium bicar¬
bonate remained the same. Only one dose was given in any one day.
It was found that, except for the "desensitizing dose" on the first day,
Case 1 showed no untoward symptoms. At the end of the eleventh
day, 2 gm. were being taken without any disagreeable symptoms. Case
2 did not respond so readily, and it was necessary to discontinue the
procedure when 0.7 gm. was taken on account of a diarrhea and some
visual disturbances. It is of interest to note that the degree of inten¬
sity of the skin reaction was in inverse ratio to the amount of quinin
ingested without ill effect. In Case 1 the cutaneous reaction gradually
became less marked, until on the tenth day it completely disappeared.
The reaction in Case 2 became gradually less distinct until 0.7 gm. was
given, but when the toxic symptoms manifested themselves there was
efflorescence which simulated in intensity that encountered in the initial
tests.
2. Heran and St. Girons: Montpellier med. 39:21, 669, 1917.
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Two other methods of desensitization were instituted in Case 2.
One was the administration of quinin bisulphate, by mouth, in increas¬
ing doses once a day. The initial dose was 0.03 gm. and it was increased
by as much each day. The other method consisted in giving a "desensi¬
tizing dose" of 0.01 gm. quinin chlorhydrosulphate in 5 mils of sterile
water, intravenously, and, after from thirty to forty-five minutes, giving
a second dose starting with 0.2 gm. of the same drug and increasing
0.1 gm. a day. By both methods 0.7 gm. could be given with safety, but
symptoms appeared if larger quantities were administered.
We are not prepared to offer a theory as to the nature of these reac¬
tions in terms of anaphylaxis or allergy. Many investigators, adherent
to either the humoral or cellular theories of anaphylaxis, agree that a
protein must be associated with its provocation, while others maintain
that proteins are not necessary. If it were true that a protein must
be involved in the production of anaphylaxis, idiosyncrasies and skin
reactions to various alkaloids, which are not proteins, would seek
explanation on some other basis. Several authors, notably Zielera and
Pöhlmann,4 have placed these phenomena in the realm of intoxications
rather than manifestations of anaphylaxis, basing their conclusions, for
the most part, on the inability to produce passive sensitization in ani¬
mals with the sera of hypersensitive persons. On the other hand,
Klaussner5 and Brück6 report passive sensitization in guinea-pigs by
injecting the sera of individuals with idiosyncrasies to drugs.
Hans Meyer has evolved a theory that there is an alteration in
the calcium content of the tissues, while, on the other hand, Pepper
and Krumbhaar7 deny that there is a deficiency in calcium metabolism
in edema and urticaria. Hunt8 and Lewis9 have shown that a certain
percentage of cases of poison susceptibility can be influenced by diet.
Kolmer,10 who has had a vast experience with skin reactions, refers
to them as "anaphylactic or pseudo-anaphylactic." He states that there
is not sufficient data at hand to prove that the mechanism of the local
or skjn anaphylactic reaction is identical with that of the general or
fatal reaction following intravenous injections. He, as well as Long-
cope,11 admits that examples of drug anaphylaxis, unless such drugs
contain protein substances, offer certain difficulties as to explanation,
3. Zieler: M\l=u"\nchen. med. Wchnschr. 59:401, 1641, 1912.
4. P\l=o"\hlmann: M\l=u"\nchen.med. Wchnschr. 61:543, 1914.
5. Klaussner: M\l=u"\nchen.med. Wchnschr. 57:1451, 1983, 1910; 58:138, 1911.
6. Bruck: Berl. klin. Wchnschr. 47:517, 1928, 1910.
7. Pepper, W., and Krumbhaar, E. B.: J. Infect. Dis. 14:476, 1917.
8. Hunt, R.: U. S. P. H. and M. H. S. Hyg. Lab. Bull. 69: 1910.
9. Lewis, J. H.: J. A. M. A. 72:329 (Feb. 1) 1919.
10. Kolmer, J. A.: Infection, Immunity and Spec. Ther., 1917, p. 617; Bull.
Johns Hopkins Hosp. 28:163 (May) 1917.
11. Longscope, W. T.: Am. J. M. Sc. 152:6125 (Nov.) 1916.
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but maintains that a drug may be capable of sensitizing body cells in
the same manner, as in the "indirect anaphylaxis" of Richet, or that a
new protein compound is formed in the patient's serum to which he may
be "actively sensitized."
SUMMARY
In the two cases of idiosyncrasy to quinin, the skin test descsibed
by Boerner has been found a good index to hypersensitiveness.
2. These cases reacted to various salts of quinin only, failing to
respond to cinchonin, cinchonidin, salicylic acid, caffein citrate, potas¬
sium iodid, atropin sulphate and epinephrin.
3. A method of desensitization described by Heran and Saint
Girons proved efficacious in one case and increased the tolerance in
another.
4. The intensity of the cutaneous reaction was found to be in
inverse ratio to the degree of desensitization obtained.12
12. Lutz, W.: Cor.-Bl. f. schweiz. Aerzte 47:1601 (Dec. 1) 1917. Sollmann,
T.: J. Pharmacol & Exper. Therap. 9:309 (March) 1917. Strickler, A.: New
York M. J. 104:198 (July 29) 1916. Zinnser: Infection and Resistance, 1919,
p. 410.
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From above downward the drugs employed were quinin bisulphate (1:10),
salicylic acid (10 per cent.), caffein citrate (10 per cent.), potassium iodid(saturated solution), atropin sulphate (0.5 per cent.) and epinephrin (1: 1,000).
Illustrating Article by John J. O'Malley, M.D., and DeWayne G. Richey, M.D.,
Archives of Internal Medicine, October, 1919
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